SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001193125-15-313499
Filing Date
2015-09-08
Accepted
2015-09-08 06:44:46
Documents
15

Document Format Files

Seq Description Document Type Size
1 FORM F-1 (AMENDMENT NO. 3) d912889df1a.htm F-1/A 2646489
2 EX-3.4 d912889dex34.htm EX-3.4 75319
3 EX-4.4 d912889dex44.htm EX-4.4 190177
4 EX-5.1 d912889dex51.htm EX-5.1 38164
5 EX-8.1 d912889dex81.htm EX-8.1 8878
6 EX-8.2 d912889dex82.htm EX-8.2 30219
7 EX-23.1 d912889dex231.htm EX-23.1 1415
8 GRAPHIC g9128891.jpg GRAPHIC 5764
9 GRAPHIC g9128892.jpg GRAPHIC 15158
10 GRAPHIC g912889g32b53.jpg GRAPHIC 51094
11 GRAPHIC g912889g52e70.jpg GRAPHIC 117011
12 GRAPHIC g912889g67a59.jpg GRAPHIC 36576
13 GRAPHIC g912889g94d16.jpg GRAPHIC 116569
14 GRAPHIC g912889img01.jpg GRAPHIC 9136
15 GRAPHIC g912889new1.jpg GRAPHIC 11092
  Complete submission text file 0001193125-15-313499.txt   3491204
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-205073 | Film No.: 151095405
SIC: 2834 Pharmaceutical Preparations